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Abstract 
Cholesterol is an essential constituent of all
mammalian cell membranes and its availability
is therefore a prerequisite for cellular growth
and other functions. Several lines of evidence
are now indicating an association between
alterations of cholesterol homeostasis and cell
cycle progression. However, the role of choles-
terol in cell differentiation is still largely
unknown. To begin to address this issue, in this
study we examined changes in cholesterol
metabolism and in the mRNA levels of proteins
involved in cholesterol import and esterifica-
tion (multi-drug resistance, MDR-3) and
acylCoA: cholesterol acyltransferase (ACAT)
and cholesterol export (caveolin-1) in Friend
virus-induced erythroleukemia cells (MELC),
in the absence or in the presence of the chem-
ical inducer of differentiation, hexamethylene
bisacetamide (HMBA). FBS-stimulated growth
of MELC was accompanied by an immediate
elevation of cholesterol synthesis and choles-
terol esterification, and by an increase in the
levels of MDR-3 and ACAT mRNAs. A decrease
in caveolin-1 expression was also observed.
However, when MELC were treated with HMBA,
the inhibition of DNA synthesis caused by
HMBA treatment, was associated with a
decrease in cholesterol esterification and in
ACAT and MDR-3 mRNA levels and an increase
in caveolin-1 mRNA. Detection of cytoplasmic
neutral lipids by staining MELC with oil red O,
a dye able to evidence CE but not FC, revealed
that HMBA-treatment also reduced growth-
stimulated accumulation of cholesterol ester to
approximately the same extent as the ACAT
inhibitor, SaH. Overall, these results indicate
for the first time a role of cholesterol esterifica-
tion and of some related genes in differentia-
tion of erythroid cells. 
Introduction
Cholesterol balance in cells is a function of
the amount taken up from extracellular
sources, the amount newly made by the cell, the
amount stored as cholesterol esters (CE) and
the amount removed by cholesterol acceptors
like high density lipoprotein (HDL). Based on
the notion that activation of cell growth impos-
es additional need for cellular cholesterol to
support membrane synthesis, a potential mech-
anism contributing to abnormal growth might
involve altered cellular sterol balance and/or
metabolism. A relationship between cholesterol
metabolism and tumoral growth has been pre-
viously shown in our laboratories in different
animal models of tumors1,2 as well as in various
types of human neoplasms,3-5 including
leukemias.6 A constant finding of these studies
was that tumors are characterized by specific
pattern of cholesterol metabolism, namely an
increase of cholesterol synthesis and an accu-
mulation of CE in tumoral cells, and a corre-
sponding decrease of HDL cholesterol in the
plasma compartment. More recently, in vitro
studies7-8 have provided a plausible association
between cholesterol esterification and the con-
trol of cell cycle progression, indicating that
cholesterol esterification may act by accelerat-
ing signal transduction pathways involved in
cell cycle control.9 Several in vitro studies have
shown that proliferation and differentiation are
inversely correlated processes.10,11 Many can-
cers exhibit both loss of normal proliferation
controls and a block in completing differentia-
tion.12 In this context, Friend virus-induced ery-
throleukemia of mice give rise to permanent
cell lines of transformed erythroid/megakary-
ocyte precursor cells that are blocked at about
the proerythroblast/megaerythroblast stage of
differentiation.13-17 Treatment of these murine
erythroleukemia cell (MELC) lines with chemi-
cal inducers of differentiation such as hexam-
ethylene bisacetamide (HMBA), causes them
to reinitiate erythroid differentiation culminat-
ing in the synthesis of hemoglobin, terminal
cell division, and loss of tumorigenicity.18-21
Such cell system offer an attractive opportunity
to better explore the coordination of rate of cell
proliferation and differentiation and choles-
terol esterification. Therefore, we assayed the
levels of newly synthesized cholesterol (free
and ester), cholesterol esterification and the
rate of growth during differentiation induced in
MELC by HMBA. Cholesterol esterification is
one of the mechanisms that cells use to control
the amount of toxic free cholesterol (FC);
under conditions of excess cholesterol, this is
transported from the plasma membrane to the
endoplasmic reticulum (ER) where is esteri-
fied.22,23
Several lines of evidence are now indicating
that caveolin-1, the key structural protein of
caveolae (cholesterol-rich membrane
microdomains) and P-glycoprotein (P-gp), the
product of the multidrug resistance (MDR-1 in
humans and the MDR-3 in rodents) gene have
inverse implications in the cholesterol metabo-
lism of normal cells. The MDR gene is involved
in the process of cholesterol esterification,
being required for transport of FC from the
plasma membrane to ER, the site of cholesterol
esterification by acyl-CoA:cholesterol acyltrans-
ferase (ACAT).24,25 In contrast, caveolin-1 is
required for translocation of cholesterol from
the ER to the plasma membrane and is involved
in cholesterol efflux.26-28
However, in spite of the fact that MDR and
caveolin-1 are recognized as playing a major
role in intracellular cholesterol ester metabo-
lism, it is still unclear why during tumor
growth, membrane cholesterol is preferentially
shifted to the ER, leading to an accumulation of
CE, rather than being released to the appropri-
ate extra cellular HDL acceptor. These observa-
tions prompted us to investigate levels of ACAT-
1, MDR-3, and caveolin-1 mRNAs during differ-
entiation of MELC induced by HMBA. 
Materials and Methods
Cell cultures, conditions for induc-tion, and reagents
MELCs (derived from the 745/A strain) were
grown in suspension using RPMI 1640 medium
(Bio-Whittaker Europe, Verviers, Belgium)
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containing 2 mM glutamine and supplemented
with 5% fetal bovine serum (FBS) Boehringer-
Mannheim, Mannheim, Germany) at 37°C in a
5% CO2-humidified atmosphere. Cells were
usually seeded at a density of 105 cells/mL and
passaged every 4-5 days. Induction of MELC dif-
ferentiation was carried out by supplementing
cultures with 5 mM HMBA (Sigma, St. Louis,
MO, USA).
At the start of the experiments, cells from the
stock cultures were diluted and seeded at a
density of l¥105 cells/mL in 10% FBS. Unless
otherwise indicated, cells were harvested at 0,
24, 48, 72, and 96 h after seeding.Analysis of cellular growth 
At the times indicated, cells supplemented
with 10% FBS were washed with PBS, harvest-
ed with trypsin/EDTA (0.05%/0.02%) and cell
number was counted using a Coulter counter.
For the thymidine incorporation studies, cells
were labelled with 3H-thymidine at 5 μCi/mL
during the last 3 hours of incubation, and
radioactivity incorporated into the DNA was
determined by trichloroacetic acid precipita-
tion of the cell lysate. Protein content was
determined by Lowry et al.29Cholesterol biosynthesis and esteri-fication 
To assess cholesterol biosynthesis, cells
were incubated in medium containing 10% of
FBS with (14C)acetate (final radioactivity of 7.4
MBq/mL) for 4 hours at 37°C in a CO2 incuba-
tor. To assess cholesterol esterification, cells
were incubated for 4 h at 37°C with (14C)oleic
acid (specific activity of 2.22 GBq/mmol, final
radioactivity of 0.185 MBq/mL; Amersham
Biosciences) complex with BSA (essentially
fatty acid-free; Sigma). Cells were washed, and
lipids were extracted and analyzed by thin layer
chromatography (TLC) as described previous-
ly.9 Spots of cholesterol and cholesteryl oleate
were identified by standards (Sigma), scraped,
and counted in a β-counter.RNA extraction, reverse transcrip-tion -PCR analysis
Total RNA was isolated from cells using the
guanidine isothiocyanate phenol-chloroform
extraction method.30 RNA yield was quantified
spectrophotometrically and A260/A280 ratios
determined. The integrity and accuracy of the
spectrophotometric measurement of each RNA
sample was assessed by electrophoresis of 1 μg
on an ethidium bromide-stained, agarose
minigel. Equal amounts of total RNA (0.5 μg)
were reverse transcribed into cDNA using oligo
dT. cDNA was subsequently amplified by the
polymerase chain reaction (PCR) in the pres-
ence of specific primers according to the
instructions provided by the manufacturer
(GeneAmp RNA PCR Kit, Perkin-Elmer Cetus).
The PCR was performed using the following
primers and conditions: for MDR-3,
5’CATCAGCCCTGTTCTTGGACT3’, 5’GAGAT-
GTTGGCCGTGATAGCT3 ’(234-bp fragment);
94°C for 30 s, 58°C for 60 s, and 72°C for 60 s
for 30 cycles. For ACAT-1, 5’TGCCTGAGC-
TACTTCTACCCA3’, 5’CACGTAACGACAAGTCCA
GGT3’ (266-bp fragment); 95°C for 30 s, 60°C
for 30 s, and 72°C for 40 s, for 30 cycles. For
caveolin-1, 5’CTACAAGCCCAACAACAAGGC 3’,
5’AGGAAGCTCTTGATGCACGGT 3’ (340 bp frag-
ment); 965°C for 25 s, 58°C for 30 s, and 73°C
for 50 s, for 30 cycles. For β-actin, 5’GCCTCTG-
GTCGTACCACTGGC3’, 5’AGGGAGGAAGAGGAT-
GCGGCA3’ (278 bp fragment); 95°C for 30 sec-
onds, 59°C for 30 seconds, and 72°C for 45 sec-
onds, for 30 cycles. Preliminary experiments
demonstrated that using these PCR conditions
the amount of product amplification to RNA
relationship was linear for the cycle number
used over the range 500-1500 ng of total RNA.
Working in these conditions PCR products sep-
arated on agarose and stained with ethidium
bromide were characterized by a major band of
the predicted size (data not shown).Blotting analysis 
During PCR reaction the nonradioactive
label Digoxigenin-11-dUTP (DIG; Boheringer
Mannheim) was incorporated and immunode-
tected with anti-digoxigenin Fab fragments
conjugated to alkaline phosphatase and visual-
ized with the chemiluminescence substrate
CSPD®. Enzymatic dephosphorylation of
CSPD® by alkaline phosphatase led to a light
emission at a maximum wavelength of 477 nm
which was recorded on X-ray films. The DNA
fragments were separated by electrophoresis
on agarose and then blotted onto a nylon mem-
brane for 16 h in 10XSSC. The blot was exposed
to X-ray film for 2-10 minutes. A Kodak Digital
Science Band Scanner Image Analysis System
containing HP ScanJet, ID Image Analysis
Software assessed the intensity of the bands in
the autoradiograms. The overall procedure was
standardized by expressing the amount of PCR
product for each target mRNA relative to the
amount of product formed for β-actin. Since a
low yield of PCR products is often obtained
when cDNA segments are coamplified with an
internal standard gene in the same tube, the
relative levels of gene expression were deter-
mined by comparing the PCR products of the
target cDNA and β-actin gene processed in sep-
arate tubes.Microscopic analysis
For microscopic analysis, MELC, grown in
suspension as described above, were treated
with 5 mM HMBA or with 4 μM of the acyl
amide ACAT inhibitor SaH 58-035 (SaH) kindly
provided by Novartis Pharma AG, Basel,
Switzerland and harvested after 72 h. To visual-
ize the degree of cytoplasmic neutral lipid (NL)
accumulation, MELC were washed three times
with PBS, and fixed by soaking in 10% forma-
lin. Cells were then treated with isopropyl alco-
hol (60%), washed, and stained with oil red O
(ORO) (a lipid-soluble dye which stains NL,
including CE, but not FC) and then counter-
stained with Mayer’s hematoxylin NL appear as
bright red spots in the cytoplasm. Cells were
imaged using a Leitz inverted-phase micro-
scope fitted with a digital camera. Statistical analysis 
Data were reported as the average
values±standard error (SE). Student’s t-test,
suitably computed by means of the grouped
data method, was used, and a probability value
of P<0.05 was regarded as statistically signifi-
cant. 
Results Inhibition of cell growth of MELC byHMBA
When the rate of cell proliferation was ana-
lyzed, about 65% fewer cells were found in
HMBA-induced cultures compared to uninduced
after 3 days of culturing, when the cultures were
approaching confluence (P<0.05) (Figure 1A).
Similarly, the rate of 3H-thymidine incorpora-
tion was consistently higher in MELC than in
HMBA-treated cells (Figure 1B). The increased
ability to growth in MELC compared with
HMBA-cells was also reflected in a higher con-
tent of proteins in the former compared with the
latter (Figure 1C).Inhibition of cholesterol esterifica-tion in MELC by HMBA 
Cholesterol biosynthesis and esterification in
MELC and HMBA-MELC were assessed as an
indirect measure of changes in intracellular
cholesterol content. The rate of (14C)acetate
incorporation into FC in control cells was almost
twice that in HMBA cells (P<0.05) (Figure 2A).
When the rate of (14C)acetate incorporation
into CE was assessed (Figure 2B), a 2-to 10-fold
lower CE synthesis was observed in HMBA cells.
Accordingly, the rate of (14C)oleic acid incorpo-
ration into CE in HMBA cells was at least 60%
lower compared with that in uninduced MELC
cells (P<0.05) (Figure 2C).PCR analysis in MELC and HMBA-cells 
To further evaluate the possibility that cho-
lesterol esterification per se may be a limiting
factor in determining cell growth and differenti-
ation, we next evaluated in MELC and HMBA-
cells, the expression of some genes implicated
in the regulation of intracellular cholesterol
trafficking: ACAT-1 and MDR-3, involved in the
import of cholesterol, and caveolin-1, in the
Article
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export. The detection of ACAT-1, MDR-3 and
caveolin-1 mRNAs has been carried out by PCR
on reverse transcripts, and analyses have
revealed the occurrence of PCR products
migrating at positions consistent with the
expected size of 266 bp, 234-bp, 340 bp, respec-
tively (data not shown). Growing MELCs were
found to express relatively high levels of ACAT-1
and MDR-3 mRNAs, which significantly
decreased during MELC induction to terminal
division by 5 mM HMBA, (Figures 3 and 4 A and
B). By contrast, caveolin-1 gene expression,
powerfully suppressed in growing MELC, aug-
mented in HMBA-induced cells (Figures 3 and
Figure 4C).
Microscopic analysis 
Finally, to examine the effects of pharmaco-
logical inhibition of cholesterol esterification on
cell growth and differentiation, we compared the
effects of HMBA with those of SaH 58-035
(SaH), a specific inhibitor of ACAT, especially
with regard to morphologic and neutral lipid
changes on MELC cultures. The results showed
that, MELC, 72 h after SaH-treatment, are small-
er and have smaller nuclei compared to untreat-
ed cells, in that resembling the 72 h HMBA-treat-
ed cells (Figure 5A). On the other hand, detec-
tion of cytoplasmic neutral lipids by staining
MELC with ORO, a dye able to evidence CE but
not FC, revealed that HMBA-treatment inhibits
Article
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Figure 1. Time course of cell growth, 3H-
thymidine incorporation and protein con-
tent in murine erythroleukemia cells
(MELC) in presence or absence of hexam-
ethylene bisacetamide (HMBA). MELC
cells were seeded at a density of 1¥105
cells/mL and stimulated to growth by
adding 10% FCS. At the indicated times A)
cell number, B) 3H-thymidine incorpora-
tion and C) protein content were deter-
mined as described in Materials and
Methods. Data are mean±Standard Error of
three independent experiments, each per-
formed in triplicate. *Indicates statistically
significant (P<0.05) compared with
MELC. 
Figure 2. Time course of 14C-acetate incor-
porated into A) free cholesterol, B) coles-
terol esters and C) 14C-oleate incorpora-
tion into Colesterol Esters of murine ery-
throleukemia cells (MELC) in presence or
absence of hexamethylene bisacetamide
(HMBA). MELC cells were seeded at a den-
sity of 1¥105 cells/mL and stimulated to
growth by adding 10% FCS 14C-acetate
and 14C-oleate were added 3 h before each
time point. MELC were harvested every 24
h for a total period of 96 h. Data are
mean±Standard Error of three independent
experiments, each performed in triplicate.
*Indicates statistically significant (P<0.05)
compared with MELC. 
Figure 4. Relative levels of Acyl-coenzyme A:
Cholesterol AcylTransferase (ACAT-1),
Multidrug Resistance (MDR-3) and
Caveolin-1 (C) mRNA in murine ery-
throleukemia cells (MELC). Reverse tran-
scription-polymerase chain reaction analysis
was performed for three independent exper-
iments. Relative levels of A) ACAT-1, B)
MDR-3 and C) Caveolin-1 (Cav-1) mRNA
were normalized to the corresponding β-
actin levels and expressed as percentage.
Figure 3. Multidrug Resistance (MDR-1),
Acyl-coenzyme A: Cholesterol Acyl
Transferase (ACAT-1) and Caveolin-1 mRNA
levels in murine erythroleukemia cells
(MELC) and hexamethylene bisacetamide
(HMBA)-induced MELC. The figure shows
representative autoradiograms of MDR-1,
ACAT-1, caveolin-1 (Cav-1) and β-actin
mRNA in MELC and in HMBA treated
MELC. Reverse transcription-polymerase
chain reaction analysis was performed as
described in Materials and Methods.
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cholesterol ester accumulation in MELC to
approximately the same extent as the ACAT
inhibitor, SaH (Figure 5B). 
Discussion 
This study attempts to evaluate a possible
role of cholesterol esterification in the regula-
tion of cell growth and differentiation. To do
this, we utilized MELC as a model of cell differ-
entiation by using either uninduced or HMBA-
induced cultures as actively proliferating or
differentiating cell populations, respectively. It
was found that cholesterol esterification is i)
enhanced during active DNA synthesis and ii)
inhibited concomitantly with pharmacological-
ly-induced cell differentiation and growth
arrest. Particularly, the rate of cholesterol
esterification seems to parallel cellular replica-
tion and, actually, precedes the onset of DNA
synthesis. Intracellular cholesterol transport
are now receiving increasing attention as
devices that cholesterol in specialized mem-
brane platform called rafts could have a role in
the regulation of a number of signal transduc-
tion pathways, including those involved in cell
division and differentiation.31 Studies with
cholesterol-depleted cells demonstrated that a
reduced level of cholesterol in the rafts is by
itself a signal to activate pathway leading to
cell division.32,33 ACAT-1, MDR-3 and caveolin-
1 are a part of the lipid transport system that
counterbalances excessive intracellular cho-
lesterol. It has been suggested that MDR-3
transports excess cholesterol from the plasma
membrane to ER where it is esterified by
ACAT.24,25 On the contrary, caveolin-1 trans-
ports cholesterol from ER to plasma membrane
where it become the preferential source of
cholesterol for efflux.27,28 As an essential com-
ponent of caveolae, caveolin-1 is also involved
in numerous signalling pathways.32-34
Involvement of these proteins in cholesterol
trafficking makes them potential targets to
improve our knowledge on the possible role of
cholesterol esterification in stimulation of
growth and differentiation. In this work, we
demonstrate that down-regulation of ACAT-1
and MDR-3 and up-regulation of caveolin-1 in
MELC are strictly correlated with cell differen-
tiation induced by HMBA. These findings raise
the possibility that MDR-3 and caveolin-1,
might specifically influence raft-dependent
signal transduction, at least in part, so rein-
forcing the possibility that cholesterol esterifi-
cation, MDR-1, caveolin-1 and signal transduc-
tion may be closely linked. The view is consis-
tent with the induction of MDR-3- and ACAT-1
and with the reduction of caveolin-1 mRNA in
MELC cell growing, and with the opposite pat-
tern observed in differentiating cells. Further
studies are necessary to provide a complete
mechanistic understanding of exactly how
cholesterol esterification regulates cell differ-
entiation, however, we could reach a tentative
hypothesis: when cells are stimulated to
divide, such as during tumorigenesis, the
intracellular cholesterol increases, however it
beside to be transported and distributed with-
in the plasma membranes in lipid rafts, accu-
mulate in the cytoplasm as CE. The conse-
quent lower levels of FC into the rafts, by
actively enhancing the integrated interchange
of signaling molecules involved in cell division,
such as Ras-MAPK cascade, may contribute to
accelerate tumor progression.35 Conversely,
when cells are stimulated to differentiation,
the inhibition of cholesterol esterification, by
increasing the expression of caveolin-1 and
possibly FC content into the rafts, may lead to
a reduction of signal transduction activa-
tion.32,33,35 Proliferating tumor cells, could be
then reprogrammed to terminal division
toward the mature phenotype with consequent
loss of tumorigenicity. 
Conclusions
The results of this study, other than to add
new insights on the possible role of cholesterol
metabolism during tumor growth, for the first
time indicate a role of cholesterol esterifica-
tion and of some related genes in differentia-
tion of erythroid cells. These findings raise the
possibility that cholesterol esterification and
related genes may emerge as a successful ther-
apeutic targets for disease characterized by a
block in differentiation, i. e. leukemias. 
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